223 research outputs found
Национальный форсайт - проект сельского хозяйства Казахстана: научно-техническая стратегия, ресурсы, приоритеты развития, конкурентоспособность.
: Innovation has become a key factor in global economic development and remain at the forefront of technological breakthrough. Developed countries pay considerable attention to conducting R&D in the segments that in the coming decades will determine megatrends of technological and social development. At the same time, a great emphasis is placed on the development of interdisciplinary scientific directions and the convergence of technologies.
Foresight helps to increase effectiveness of the decision-making process, ensuring a high level of transparency, through the involvement of all stakeholders. In addition, foresight increases awareness of participants about possible scenarios and risks of the future, as well as opportunities that should not be missed
Measuring high-order photon-number correlations in multimode pulsed quantum states
We implement a direct detection scheme based on hybrid photodetectors to
experimentally investigate high-order correlations for detected photons by
means of quantities that can be experimentally accessed. We show their
usefulness in fully characterizing a multimode twin-beam state in comparison
with classical states and, in particular, we introduce a nonclassicality
criterion based on a simple linear combination of high-order correlation
functions. Our scheme is self-consistent, allowing the estimation of all the
involved parameters (quantum efficiency, number of modes and average energy)
directly from the same experimental data. Results are in very good agreement
with theory, thus suggesting the exploitation of our scheme for reliable state
characterization in quantum technology.Comment: 4 figure
Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines
Everolimus (Eve) is an FDA approved drug that inhibits mammalian target of rapamycin (mTOR). It is employed in breast cancer treatment even if its responsiveness is controversial. In an attempt to increase Eve effectiveness, we have developed a novel Eve nanoformulation exploiting H-ferritin nanocages (HEve) to improve its subcellular delivery. We took advantage of the natural tumor targeting of H-Ferritin, which is mediated by the transferrin receptor-1 (TfR1). Breast cancer cells overexpressing TfR-1 were successfully recognized by H-Ferritin, displaying quick nanocage internalization. HEve has been tested and compared to Eve for in vitro efficacy in sensitive and resistant breast cancer cells. Nanoformulated Eve induced remarkable antiproliferative activity in vitro, making even resistant cell lines sensitive to Eve. Moreover, the antiproliferative activity of HEve is fully in accordance with cytotoxicity observed by cell death assay. Furthermore, the significant increase in anticancer efficacy displayed in HEve-treated samples is due to the improved drug accumulation, as demonstrated by UHPLC-MS/MS quantifications. Our findings suggest that optimizing Eve subcellular delivery, thanks to nanoformulation, determines its improved antitumor activity in a panel of Eve-sensitive or resistant breast cancer cell lines
A simple synthesis of N-perfluoroacylated and N-acylated glycals of neuraminic acid with a cyclic aminic substituent at the 4\u3b1 position as possible inhibitors of sialidases
A simple protocol for the synthesis of N-perfluoroacylated and N-acylated glycals of neuraminic acid, having a secondary cyclic amines (morpholine or piperidine) at the 4\u3b1 position, has been set-up, starting from peracetylated N-acetylneuraminic acid methyl ester that undergoes, sequencially to its direct N-transacylation followed by a C-4 amination, a \u3b2-elimination, and a selective hydrolysis of the ester functions, without affecting the sensitive perfluorinated amid
Linearized texture of three-dimensional extracellular matrix is mandatory for bladder cancer cell invasion
In the fields of biomaterials and tissue engineering simulating the native microenvironment is of utmost importance. As a major component of the microenvironment, the extracellular matrix (ECM) contributes to tissue homeostasis, whereas modifications of native features are associated with pathological conditions. Furthermore, three-dimensional (3D) geometry is an important feature of synthetic scaffolds favoring cell stemness, maintenance and differentiation. We analyzed the 3D structure, geometrical measurements and anisotropy of the ECM isolated from (i) human bladder mucosa (basal lamina and lamina propria) and muscularis propria; and, (ii) bladder carcinoma (BC). Next, binding and invasion of bladder metastatic cell line was observed on synthetic scaffold recapitulating anisotropy of tumoral ECM, but not on scaffold with disorganized texture typical of non-neoplastic lamina propria. This study provided information regarding the ultrastructure and geometry of healthy human bladder and BC ECMs. Likewise, using synthetic scaffolds we identified linearization of the texture as a mandatory feature for BC cell invasion. Integrating microstructure and geometry with biochemical and mechanical factors could support the development of an innovative synthetic bladder substitute or a tumoral scaffold predictive of chemotherapy outcomes
Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy
Cancer-associated fibroblasts (CAF) are the most abundant cells of the tumor stroma and they critically influence cancer growth through control of the surrounding tumor microenvironment (TME). CAF-orchestrated reactive stroma, composed of pro-tumorigenic cytokines and growth factors, matrix components, neovessels, and deregulated immune cells, is associated with poor prognosis in multiple carcinomas, including breast cancer. Therefore, beyond cancer cells killing, researchers are currently focusing on TME as strategy to fight breast cancer. In recent years, nanomedicine has provided a number of smart delivery systems based on active targeting of breast CAF and immune-mediated overcome of chemoresistance. Many efforts have been made both to eradicate breast CAF and to reshape their identity and function. Nano-strategies for CAF targeting profoundly contribute to enhance chemosensitivity of breast tumors, enabling access of cytotoxic T-cells and reducing immunosuppressive signals. TME rearrangement also includes reorganization of the extracellular matrix to enhance permeability to chemotherapeutics, and nano-systems for smart coupling of chemo- and immune-therapy, by increasing immunogenicity and stimulating antitumor immunity. The present paper reviews the current state-of-the-art on nano-strategies to target breast CAF and TME. Finally, we consider and discuss future translational perspectives of proposed nano-strategies for clinical application in breast cancer
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model
Neoadjuvant chemotherapy has been established as the standard of care for HER2-positive breast cancer since it allows cancer down-staging, up to pathological complete response. The standard of care in the neoadjuvant setting for HER2-positive breast cancer is a combination of highly cytotoxic drugs such as anthracyclines and the anti-HER2 monoclonal antibody. Despite this cocktail allows a pathological complete response in up to 50%, their co-administration is strongly limited by intrinsic cardiotoxicity. Therefore, only a sequential administration of anthracyclines and the anti-HER2 treatment is allowed. Here, we propose the anthracycline formulation in H-Ferritin nanocages as promising candidate to solve this unmet clinical need, thanks to its capability to increase anthracyclines efficacy while reducing their cardiotoxicity. Treating a murine model of HER2-positive breast cancer with co-administration of Trastuzumab and H-Ferritin anthracycline nanoformulation, we demonstrate an improved tumor penetration of drugs, leading to increased anticancer efficacy and reduced of cardiotoxicity
Impact of semi-solid formulations on skin penetration of iron oxide nanoparticles
Background: This work aimed to provide useful information on the incidence of the choice of formulation in semi-solid preparations of iron-oxide nanoparticles (IONs). The appropriate analytical methods to assess the IONs physical stability and the effect of the semi-solid preparations on IONs human skin penetration were discussed. The physical stability of IONs (Dh = 31 \ub1 4 nm; \u3b6 = -65 \ub1 5 mV) loaded in five semi-solid preparations (0.3% w/v), namely Carbopol gel (CP), hydroxyethyl cellulose gel (HEC), carboxymethylcellulose gel (CMC), cetomacrogol cream (Cet) and cold cream was assessed by combining DLS and low-field pulsed NMR data. The in vitro penetration of IONs was studied using human epidermis or isolated stratum corneum (SC). Results: Reversible and irreversible IONs aggregates were evidenced only in HEC and CMC, respectively. IONs diffused massively through SC preferentially by an intercellular pathway, as assessed by transmission electron microscopy. The semi-solid preparations differently influenced the IONs penetration as compared to the aqueous suspension. Cet cream allowed the highest permeation and the lowest retained amount, while cold cream and CP favored the accumulation into the skin membrane. Conclusion: Basic cutaneous semi-solid preparations could be used to administer IONs without affecting their permeation profile if they maintained their physical stability over time. This property is better discriminated by low-field pulsed NMR measurements than the commonly used DLS measurements
Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells
Targeted therapies have profoundly changed the clinical prospect in human epidermal growth
factor receptor 2 (HER2)-positive breast cancer. In particular, the anti-HER2 monoclonal antibody
trastuzumab represents the gold standard for the treatment of HER2+ breast cancer patients. Its
contribution in dampening cancer progression is mainly attributed to the antibody-dependent cellmediated
cytotoxicity (ADCC) rather than HER2 blockade. Here, multiple half chains of trastuzumab
were conjugated onto magnetic iron oxide nanoparticles (MNP-HC) to develop target-specifc and
biologically active nanosystems to enhance anti-HER2 therapeutic potential. HER2 targeting was
assessed in diferent human breast cancer cell lines, where nanoparticles triggered site-specifc
phosphorylation in the catalytic domain of the receptor and cellular uptake by endocytosis. MNP-HC
induced remarkable antiproliferative efect in HER2+ breast cancer cells, exhibiting enhanced
activity compared to free drug. Accordingly, nanoparticles induced p27kip1 expression and cell cycle
arrest in G1 phase, without loosing capability to prime ADCC. Finally, MNP-HC afected viability of
trastuzumab-resistant cells, suggesting interference with the resistance machinery. Our fndings
indicate that multiple arrangement of trastuzumab half chain on the nanoparticle surface enhances
anticancer efcacy in HER2+ breast cancer cells. Powerful inhibition of HER2 signaling could promote
responsiveness of resistant cells, thus suggesting ways for drug sensitization
- …